
X
Hepatitis drug could be tested against COVID-19 in India
https://pharmaphorum.com/news/hepatitis-drug-interferon-could-be-tested-against-covid-19-in-india/
Federal judge throws out Merck’s patent claim against Gilead
Cost-effectiveness body backs combination drug Zepatier.
Roche’s MS drug is among major drugs still to come in 2016.
NOhep campaign supports action against hepatitis.
Firm hopes Epclusa will give an edge over rivals.
All of the WHO’s 194 member states have voted to eliminate viral hepatitis by 2030 as part of a global strategy.